Enterolactone levels and prognosis after invasive postmenopausal breast cancer: Potential effect modifiers.

被引：0
|
作者：
Seibold, Petra [1 ]
Buck, Katharina [1 ]
Vrieling, Alina [2 ]
Johnson, Theron [1 ]
Kaaks, Rudolf [1 ]
Linseisen, Jakob [3 ]
Heinz, Judith [4 ]
Obi, Nadia [4 ]
Flesch-Janys, Dieter [4 ]
Chang-Claude, Jenny [1 ]
机构：
[1] German Canc Res Ctr, Heidelberg, Germany
[2] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[3] German Res Ctr Environm Hlth, Munich, Germany
[4] Univ Canc Ctr Hamburg, Hamburg, Germany
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-115
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
115
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study
    Guglielmini, Pamela
    Rubagotti, Alessandra
    Boccardo, Francesco
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (02) : 661 - 668
  • [42] Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study
    Pamela Guglielmini
    Alessandra Rubagotti
    Francesco Boccardo
    [J]. Breast Cancer Research and Treatment, 2012, 132 : 661 - 668
  • [43] New potential biomarkers for breast cancer prognosis
    Havrysh, K.
    Kiyamova, R.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [44] Incidence of Invasive Breast Cancer in Postmenopausal Women After Discontinuation of Long-Term Raloxifene Administration
    Vogel, Victor G.
    Qu, Yongming
    Wong, Mayme
    Mitchell, Beth
    Mershon, John L.
    [J]. CLINICAL BREAST CANCER, 2009, 9 (01) : 45 - 50
  • [45] Effect of raloxifene on invasive breast cancer incidence by baseline breast cancer risk in postmenopausal women at risk for major coronary events.
    Geiger, M. J.
    Song, J.
    Dowsett, S. A.
    Barrett-Connor, E.
    Cauley, J.
    Grady, D.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S169 - S169
  • [46] Influence of Hormone Therapy Prior to Breast Cancer Diagnosis on Prognosis of Postmenopausal and Perimenopausal Breast Cancer Patients
    Baumgaertner, A. K.
    Haeusler, A.
    Seifert-Klauss, V. R.
    Schuster, T.
    Schwarz-Boeger, U.
    Kiechle, Klinikum M.
    [J]. CANCER RESEARCH, 2010, 70
  • [47] Is weight of the breast associated with hormone receptor expression in postmenopausal women with invasive breast cancer?
    Housmans, S
    Vanspauwen, R
    Christiaens, MR
    Drijkoningen, M
    Vergote, I
    Berteloot, P
    Amant, F
    Tonglet, R
    Neven, P
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S89 - S90
  • [48] Identification of potential non-invasive biomarkers for breast cancer prognosis and treatment by systematic bioinformatics analysis
    He, Lang
    Wang, Dan
    Guo, Zheng
    [J]. 2015 7TH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY IN MEDICINE AND EDUCATION (ITME), 2015, : 117 - 120
  • [49] Urinary phytoestrogen excretion and breast cancer risk: Evaluating potential effect modifiers endogenous estrogens and anthropometrics
    Dai, Q
    Franke, AA
    Yu, H
    Shu, XO
    Jin, F
    Hebert, JR
    Custer, LJ
    Gao, YT
    Zheng, W
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (06) : 497 - 502
  • [50] Effect of anastrozole and tamoxifen on serum lipid levels in Japanese postmenopausal women with early breast cancer
    Sawada, S
    Sato, K
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S31 - S32
12345